US 12390462
Muscarinic acetylcholine M1 receptor antagonists
granted A61KA61K31/4995A61K31/501
Quick answer
US patent 12390462 (Muscarinic acetylcholine M1 receptor antagonists) held by Contineum Therapeutics, Inc. expires Mon Aug 14 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Contineum Therapeutics, Inc.
- Grant date
- Tue Aug 19 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 14 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K31/4995, A61K31/501, A61K45/06